Table 5 Distribution frequency of WISP1polymorphisms in controls and gastric cancer patients stratified by cell differentiation

rs2929973

 Co-dominant TT

102(44.9)

81(48.2)

1.00^ref

19(52.8)

1.00^ref

 TG

91(40.1)

72(42.9)

1.03(0.65–1.62)

13(36.1)

0.86(0.36–2.07)

 GG

34(15.0)

15(8.9)

0.60(0.29–1.21)

4(11.1)

0.96(0.27–3.39)

 Dominant TT

102(44.9)

81(48.2)

1.00^ref

19(52.8)

1.00^ref

 TG + GG

125(55.1)

87(51.8)

0.90(0.58–1.37)

17(47.2)

0.88(0.39–1.99)

 Recessive TT + TG

193(85.0)

153(91.1)

1.00^ref

32(88.9)

1.00^ref

 GG

34(15.0)

15(8.9)

0.59(0.30–1.14)

4(11.1)

1.03(0.31–3.42)

rs7843546

 Co-dominant CC

36(15.9)

34(20.2)

1.00^ref

7(19.4)

1.00^ref

 CT

119(52.4)

86(51.2)

0.79(0.45–1.41)

23(63.9)

1.14(0.40–3.24)

 TT

72(31.7)

48(28.6)

0.71(0.38–1.31)

6(16.7)

0.42(0.11–1.56)

 Dominant CC

36(15.9)

34(20.2)

1.00^ref

7(19.4)

1.00^ref

 CT + TT

191(84.1)

134(79.8)

0.77(0.45–1.32)

29(80.6)

0.87(0.31–2.39)

 Recessive CT + CC

155(68.3)

120(71.4)

1.00^ref

30(83.3)

1.00^ref

 TT

72(31.7)

48(28.6)

0.86(0.54–1.35)

6(16.7)

0.38(0.14–1.07)

rs10956697

 Co-dominant CC

86(37.9)

79(47.0)

1.00^ref

16(44.4)

1.00^ref

 AC

114(50.2)

70(41.7)

0.73(0.46–1.14)

18(50.0)

0.90(0.39–2.04)

 AA

27(11.9)

19(11.3)

0.96(0.47–1.93)

2(5.6)

0.67(0.13–3.55)

 Dominant CC

86(37.9)

79(47.0)

1.00^ref

16(44.4)

1.00^ref

 AC + AA

141(62.1)

89(53.0)

0.76(0.49–1.16)

20(55.6)

0.86(0.39–1.93)

 Recessive CC + AC

200(88.1)

149(88.7)

1.00^ref

34(94.4)

1.00^ref

 AA

27(11.9)

19(11.3)

1.12(0.58–2.17)

2(5.6)

0.71(0.14–3.55)